OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics, Inc. (OKUR) is a healthcare company (biotechnology) based in the United States. The share price is $2.53, down 8.00% on the day, which values the company at $104.21M. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

Key facts

Share price
$2.53−8.00% today
Market value
$104.21M
200-week average
$21.3688% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

OnKure Therapeutics, Inc. in more detail

OKUR trades at -1.6× next year's expected earnings. It sits 88% below its 200-week average of $21.36.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Thin interest cover.

1 of the superinvestors tracked here hold OKUR, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding OKUR

1 of the investors tracked here report a position in their latest 13F filing.

OnKure Therapeutics, Inc. (OKUR): questions and answers

What is OnKure Therapeutics, Inc.'s market cap?

OnKure Therapeutics, Inc. is valued at $104.21M at a share price of $2.53.

Is OKUR above its 200-week moving average?

No. OKUR is 88.2% below its 200-week average of $21.36. Long-term investors watch that line because strong companies rarely trade below it for long.

Does OKUR pay a dividend?

OnKure Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own OKUR?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold OKUR. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “OnKure Therapeutics, Inc. (OKUR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OKUR

Underlying data: Yahoo Finance; company filings with the SEC.